Skip to main content
TipRanks
Go Ultimate75% OFF

Alastair Clemow Insider Profile

4 Followers

Alastair Clemow, former Director at Aevi Genomic Medicine, holds 37.70K shares in Aevi Genomic Medicine (Ticker: ~GNMX), holds 280.31K shares in Prolor Biotech (Ticker: PBTH). Most recently, Alastair Clemow Bought ― shares of Aevi Genomic Medicine on Oct 18, 2017 for an estimated value of $25.00K.

Alastair Clemow's Trading History

~GNMX
Aevi Genomic Medicine
Oct 18, 2017―Informative Buy25.00K$8.75K
PBTH
Prolor Biotech
――――

You May Also Like

Alastair Clemow insider profile FAQ

What is the percentage of profitable transactions made by Alastair Clemow?
The percentage of profitable transactions made by Alastair Clemow is 50%.
What is the average return per transaction made by Alastair Clemow?
The average return per transaction made by Alastair Clemow is 29.80%.
What stocks does Alastair Clemow hold?
Alastair Clemow holds: ~GNMX, PBTH stocks.
What was Alastair Clemow’s latest transaction?
Alastair Clemow’s latest transaction was an Informative Buy of $25.00K.
What was Alastair Clemow's most profitable transaction?
Alastair Clemow’s most profitable transaction was an Informative Buy of ~GNMX stock on December 1, 2014. The return on the trade was 61.90%.
What is Alastair Clemow's role in Aevi Genomic Medicine?
Alastair Clemow's role in Aevi Genomic Medicine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.